Medicare Enrolled
Dr. Barry Riskin, MD
Neurology · Bloomington, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Riskin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Riskin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Riskin
Dr. Barry Riskin is a neurology specialist in Bloomington, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Riskin performed 2,461 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Riskin received a total of $141,220 from 40 pharmaceutical and/or device companies across 307 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Riskin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 13% volume in IL
$141,220 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,461
Medicare services
Top 13% in IL for neurology
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
712 | $90 | $252 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
220 | $117 | $394 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
200 | $69 | $596 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
200 | $10 | $57 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
197 | $1 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
166 | $8 | $32 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
134 | $14 | $143 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
113 | $3 | $49 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
111 | $15 | $153 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
90 | $97 | $746 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
76 | $156 | $1,058 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
59 | $39 | $430 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
42 | $16 | $151 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
30 | $5 | $64 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
29 | $29 | $286 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
26 | $10 | $111 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
24 | $8 | $67 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
19 | $6 | $50 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
13 | $10 | $96 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$141,220
Total received (2018-2024)
Avg $20,174/year across 7 years
Top 6% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
307
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$39,140
2023
$1,410
2022
$815
2021
$104
2020
$61
2019
$34,423
2018
$65,266
Payments by company (2024)
ACADIA Pharmaceuticals Inc
$22,503
Eisai Inc.
$15,965
Alexion Pharmaceuticals, Inc.
$200
MDD US Operations, LLC
$134
Lilly USA, LLC
$50
Supernus Pharmaceuticals, Inc.
$46
PFIZER INC.
$45
Novartis Pharmaceuticals Corporation
$42
UCB, Inc.
$40
EMD Serono, Inc.
$31
Teva Pharmaceuticals USA, Inc.
$21
Genentech USA, Inc.
$18
Mallinckrodt Hospital Products Inc.
$16
ABBVIE INC.
$16
Neurocrine Biosciences, Inc.
$14
Top 3 companies account for 98.8% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$99,623
ACADIA Pharmaceuticals Inc
$22,584
Eisai Inc.
$16,032
Supernus Pharmaceuticals, Inc.
$385
EMD Serono, Inc.
$346
MDD US Operations, LLC
$232
Alexion Pharmaceuticals, Inc.
$230
Novartis Pharmaceuticals Corporation
$225
Amneal Pharmaceuticals LLC
$135
PFIZER INC.
$133
Avion Pharmaceuticals
$96
UCB, Inc.
$91
ARGENX US, INC.
$77
Octapharma USA, Inc.
$75
Teva Pharmaceuticals USA, Inc.
$75
Kyowa Kirin, Inc.
$69
AbbVie Inc.
$69
Corium, LLC
$64
Lilly USA, LLC
$64
ABBVIE INC.
$58
Optinose US, Inc.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$47
Celgene Corporation
$46
Genentech USA, Inc.
$44
Lundbeck LLC
$35
Neurocrine Biosciences, Inc.
$35
Mallinckrodt Hospital Products Inc.
$34
Sunovion Pharmaceuticals Inc.
$31
Horizon Therapeutics plc
$28
GE HealthCare
$25
Amgen Inc.
$25
Inspire Medical Systems, Inc.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$24
Janssen Pharmaceuticals, Inc
$23
Acorda Therapeutics, Inc
$22
Alnylam Pharmaceuticals Inc.
$19
TG THERAPEUTICS, INC.
$15
Abbott Laboratories
$14
Exeltis, USA Inc.
$14
SANOFI-AVENTIS U.S. LLC
$7
Top 3 companies account for 97.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · Adlarity · Aimovig · Apokyn · BRIUMVI · COSENTYX · Dhivy · EMGALITY · GOCOVRI · Gocovri · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NO PRODUCT DISCUSSED · NOURIANZ · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONPATTRO · Ocrevus · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · Qelbree · RADICAVA · RYTARY · Rystiggo · SOLIRIS · UBRELVY · ULTOMIRIS · UPLIZNA · VYEPTI · VYVGART · Xhance · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
8
County median income
$78,329
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH MEDICAL CENTER
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Riskin is a clinical cardiology specialist, with above-average Medicare volume (top 13% in IL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Riskin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Riskin performed 712 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Riskin receive payments from pharmaceutical companies?
Yes. Dr. Riskin received a total of $141,220 from 40 companies across 307 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Riskin's costs compare to other neurologists in Bloomington?
Dr. Riskin's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Riskin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bloomington
Browse neurologists in Bloomington ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in IL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in IL
Which IL neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology